A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Masaaki Okajima, Satoru Miura, Satoshi Watanabe, Hiroshi Tanaka, Kazuhiko Ito, Takashi Ishida, Masato Makino, Akira Iwashima, Naoya Matsumoto, Kazuhiro Sato, Kosuke Ichikawa, Tetsuya Abe, Hirohisa Yoshizawa, Toshiaki Kikuchi